Clinical efficacy and indication of acetazolamide treatment on sleep apnea syndrome

Psychiatry and Clinical Neurosciences

Volumn 53, Issue 2, 1999, Pages 321-322

  Inoue, Yuichi ^a   Takata, Kokichi ^b   Sakamoto, Izumi ^b   Hazama, Hidebumi ^c   Kawahara, Ryuzo ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b National Sanatorium Nishi Tottori Hospital   (Japan)

^c Yasugi Daiichi Hospital   (Japan)

Author keywords

Acetazolamide; Efficacy; Indication; Sleep apnea syndrome; Uvulopalatopharyngoplasty

Indexed keywords

ACETAZOLAMIDE;

ADULT; ARTICLE; BODY MASS; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; SLEEP APNEA SYNDROME; TREATMENT INDICATION; TREATMENT PLANNING; UVULOPALATOPHARYNGOPLASTY;

ACETAZOLAMIDE; BODY MASS INDEX; CARBONIC ANHYDRASE INHIBITORS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PALATE, SOFT; PHARYNX; POLYSOMNOGRAPHY; SLEEP APNEA SYNDROMES; TREATMENT OUTCOME; UVULA;

EID: 0033036627     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1819.1999.00551.x     Document Type: Article

References (5)

1. Petri N, Suadicani P, Wildschiodtz K et al. Predictive value of Muller maneuver, ceplalometry and clinical feature for the outcome of UPPP. Acta Otolaryngol. 1994; 114: 565-571.
2. Sakamoto T, Nakazawa Y, Hashizume Y et al. Effects of acetazolamide on the sleep apnea syndrome and its therapeutic mechanism. Psychiatry Clin. Neurosci. 1995; 49: 59-64.
3. Sharp JT, Druz WS, D'Souza V et al. Effect of metabolic acidosis upon sleep apnea. Chest 1985; 87: 619-624.
4. White DP, Zwillich CW, Pickett C et al. Central sleep apnea: Improvement with acetazolamide therapy. Arch. Intern. Med. 1982; 142: 1816-1819.
5. Whyte KF, Gould GA, Airlie MAA et al. Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome. Sleep 1988; 11: 463-472.